NSW Australia. Genotype 1b 30+ years, F0-F1, VL 91,000 Feb 2015 (740,000 in 2010), Tx naive.
Ordered Sof/Dac from Buyers Club 21 Sept, received 14 Oct.
Virus UNDETECTED at 3 weeks AND 12 weeks (EOT) AND SVR4 AND SVR12 AND SVR24.
A thousand thankyous to Dr James and the amazing FixHepC team.
This is a recent article from the New Zealand Medical Journal and its commentary in relation to the TPPA.
Generic protections for healthy public policy are fragmented, inconsistent and weak
The TPPA does contain a number of provisions that governments can use to defend healthy public policies against foreign country or foreign company disputes (see Technical Barriers to Trade Chapter 8, Investment Chapter 9 and Annex 9B, Intellectual Property Chapter 18, Exceptions Chapter 29, Annex II New Zealand). However, the defences for health are illogical, incoherent and incomplete. The following illustrate this incoherent picture.
Some clauses state a principle, some are for “protection”, others for “preservation”, others relate to “problems”, or offer “sensitivity to objectives”. Some are for “health”, others for “public health”. Human life, safety, nutrition and availability of medicines are sometimes named separately from health. While this messy terminology may reflect ignorance and piecemeal drafting, the vague wording of these health clauses contrasts with the precise language used in other areas of the Agreement (such as the explicit, extraordinarily broad definition of “investment” and the careful elaboration of other terms in the text to reduce doubt in interpretation). These ambiguous provisions could open governments to threats, delay tactics and disputes from foreign countries and foreign companies. It is far from clear how these unclear clauses would support, for example, the obesity and alcohol measures recommended by the New Zealand Medical Association.22,23
The tpp is bad news for every HUMAN on the planet, and corporations are NOT people (although our gov't illogically says they are).
GT 2b; since 80's, no prior tx, sofosbuvir and daclatasvir compounded from API's at Kingswood Pharmacy in Sydney, started tx nov 6,2015, undetected at 4 wks, UND at 8 weeks, UND at 1 week after EOT, UND at 4 weeks after EOT and UND at 8 weeks after EOT. " I feel GOOD!! I knew that I WOULD!"
Pharmaceutical companies pushed for the extension of drug patents, data exclusivity, biologics exclusivity, and stringent copyright terms in the Trans-Pacific Partnership (TPP). Though they didn’t get everything they wanted — and are throwing a hissy fit demanding the TPP be renegotiated — is their claim that R&D justifies these demands accurate? Just exactly how much does Big Pharma pay for R&D of a new drug?
A drug funded research team claimed R&D costs average $1.32 billion (in 2011 dollars) per drug. An analysis of this study finds the cost is closer to $75 million.